Cargando…

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later

The diagnosis of substance use disorder is currently based on the presence of specifically identified behavioral symptoms. In addition, other psychiatric signs and symptoms accompany addictive behavior, contributing to the full picture of patients’ psychopathologic profile. Historically, such sympto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pani, Pier Paolo, Maremmani, Angelo G. I., Pacini, Matteo, Trogu, Emanuela, Gessa, Gian Luigi, Ruiz, Pedro, Maremmani, Icro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Concept Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356689/ https://www.ncbi.nlm.nih.gov/pubmed/32570932 http://dx.doi.org/10.3390/jcm9061913

Ejemplares similares

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
por: Maremmani, Icro, et al.
Publicado: (2010)

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
por: Maremmani, Icro, et al.
Publicado: (2015)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2012)

Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
por: Pani, Pier Paolo, et al.
Publicado: (2016)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment
por: Maremmani, Angelo G. I., et al.
Publicado: (2016)

The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability
por: Carbone, Manuel Glauco, et al.
Publicado: (2021)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
por: Lovrecic, Barbara, et al.
Publicado: (2019)

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
por: Barbuti, Margherita, et al.
Publicado: (2023)

Substance Use/Dependence in Psychiatric Emergency Setting Leading to Hospitalization: Predictors of Continuity of Care
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2022)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Randomized Trial on the Effects of a Mindfulness Intervention on Temperament, Anxiety, and Depression: A Multi-Arm Psychometric Study
por: Poli, Andrea, et al.
Publicado: (2022)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Trends of Hospitalization for Acute Alcohol Intoxication in Slovenian Children and Adolescents with and without Dual Disorder. Implications for a Correct Intervention
por: Lovrecic, Mercedes, et al.
Publicado: (2020)

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers
por: Cipollone, Giada, et al.
Publicado: (2020)

Selection, Addiction and Catalysis: Emerging Trends for the Incorporation of Noncanonical Amino Acids into Peptides and Proteins in Vivo
por: Mayer, Clemens
Publicado: (2019)

Contemporary Perspective on Addictive Behaviors: Underpinning Mechanisms, Assessment, and Treatment
por: Cimino, Silvia, et al.
Publicado: (2018)

Editorial: Neurobiological Biomarkers for Developing Novel Treatments of Substance and Non-substance Addiction
por: Liu, Yi, et al.
Publicado: (2021)

Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model
por: Cenci, Davide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84b9ve0videh2l7p2viagtf5la